Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab (Q39426629)
Jump to navigation
Jump to search
scientific article published on 2 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab |
scientific article published on 2 May 2013 |
Statements
1 reference
Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab (English)
1 reference
Zi-Zhen Xu
1 reference
Zu-Guang Xia
1 reference
Ai-Hua Wang
1 reference
Wen-Fang Wang
1 reference
Zhi-Yin Liu
1 reference
Li-Yun Chen
1 reference
Jun-Min Li
1 reference
2 May 2013
1 reference
1 reference
1351-1358
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference